Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Treg Cells May Orchestrate Muscle Repair after Injury

Lara C. Pullen, PhD  |  May 30, 2014

As our understanding of regulatory T (Treg) cells expands, so does our appreciation that Treg cells are heterogeneous and capable of exerting influence beyond the immune system. A new study suggests that Treg cells and a growth factor (Amphiregulin) produced by these cells may play an important role in wound and muscle repair.

In a paper published last December in Cell, researcher Dalia Burzyn, PhD, of Harvard Medical School in Boston, and her colleagues describe a significant and persistent accumulation of Treg cells in damaged muscle days after injury that corresponds with a switch in the myeloid cell infiltrate from a proinflammatory to a proregenerative phenotype.1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

In their research, the team performed microarray-based, gene-expression profiling of Treg cells and conventional CD4+ T cells from muscles and lymphoid organs. They report that muscle Treg cells are distinguished from splenic Treg cells in that the gene Satb1 is repressed, theoretically enhancing the suppressor activity of Treg cells in the muscle.

“We selected several of the genes upregulated in muscle Treg cells and confirmed their induced expression at the protein level by flow cytometry. Such an analysis also revealed muscle Tregs to be high level expressors of Helios and Neuropiplin and were therefore likely to be Treg cells exported as such from the thymus,” wrote the authors.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The T cell receptor (TCR) repertoires of injured-muscle and lymphoid-organ Treg cells also appear to be distinct. The investigators assessed clonality of the muscle Treg population by examining the TCR of individually sorted cells. They found that individual muscle Treg cells often had the same TCR. Thus, the rapid accumulation of Treg cells at the injury site appears to be the result of clonal expansion to an as-yet-unidentified antigen.

The team found that muscle repair after acute injury was impaired in the absence of Treg cells. They investigated this by using a strain of mice in which the diphtheria toxin receptor is expressed under the control of Foxp3 regulatory elements. They performed punctual depletion of Treg cells in these mice and documented a prolonged proinflammatory infiltrate and impaired muscle repair.

The investigators also report that muscle Treg cells expressed Amphiregulin, which improved muscle repair in vivo and acted directly on muscle satellite cells in vitro.

“When Tregs are depleted, the functionality of muscle progenitors is decreased and more fibrosis is observed. This is very interesting because it shows that Tregs can control immunological and nonimmunological processes,” wrote Dr. Burzyn in an e-mail to The Rheumatologist.

Page: 1 2 | Single Page
Share: 

Filed under:Research Rheum Tagged with:injuryResearchrheumatology

Related Articles

    T Cells & Autoimmune Diseases

    December 1, 2014

    New investigational strategy provides way to identify, characterize autoreactive T cells that escape thymic selection and cause autoimmunity

    T Cells in Systemic Lupus Erythematosus

    August 1, 2011

    Progress toward targeted therapy

    2014 ACR/ARHP Annual Meeting: Regulatory T Cells

    April 1, 2015

    Rheumatology experts explore ways Treg cells contribute to autoimmune diseases, RA

    Protein Phosphatase 2A and Regulatory T Cell Function Researched

    June 13, 2016

    The serine-threonine protein phosphatase 2A (PP2A) enzyme is critical for regulatory T cells to function—without it, they don’t have the ability to suppress effector T cells and can’t protect against autoimmunity, according to new research published in Nature Immunology. Researchers found that conditional knockout mice—in which PP2A expression is knocked out only in regulatory T cells—developed…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences